Asia Pacific Pigmentation Disorder Treatment Market Size, Share & Industry Trends Analysis Report By Type (Vitiligo, Melasma), By Treatment (Corticosteroids, Calcineurin Inhibitor, and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

The Asia Pacific Pigmentation Disorder Treatment Market would witness market growth of 5.6% CAGR during the forecast period (2023-2030).

Skin pigmentation diseases are conditions that influence the natural pigmentation of the skin. Melanin is the pigment responsible for the colour of skin. It is produced by melanocytes, which are a type of skin cell. A variety of medical conditions may cause skin pigmentation disorders. Pigmentation disorders can manifest as hypopigmentation, depigmentation, or hyperpigmentation. In depigmentation, the pigment is eliminated, leaving behind colourless skin, whereas in hypopigmentation, it is diminished. Several conditions, including vitiligo, dark skin, and melasma, can cause skin pigmentation. Conditions characterized by hypopigmentation include vitiligo, pityriasis alba, tinea versicolor, and post-inflammatory hypopigmentation.

During the forecast period, the growth of the market is anticipated to be fuelled by the aging population. As aging skin becomes more avascular and causes the skin of older people to be more pronouncedly paler, for example, the senior population is more susceptible to certain pigmentation problems.

Many elderly individuals seek treatments to address signs of aging, including pigmentation disorders. There is a strong desire among the aging population in APAC to maintain a youthful appearance, including clear and even-toned skin. In some APAC countries, the aging population have higher disposable incomes, allowing them to invest in skincare and pigmentation disorder treatments. Some countries in the APAC region, such as South Korea and Thailand, have become popular destinations for medical tourism, including cosmetic and dermatological procedures. International patients seek treatment for pigmentation disorders while traveling to these countries. The development of the aging population in the APAC region presents opportunities for the market.

The China market dominated the Asia Pacific Pigmentation Disorder Treatment Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $86.8 million by 2030. The Japan market is registering a CAGR of 4.9% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 6.2% during (2023 - 2030).

Based on Type, the market is segmented into Vitiligo, Melasma, and Others. Based on Treatment, the market is segmented into Corticosteroids, Calcineurin Inhibitor, and Others. Based on Distribution Channel, the market is segmented into Drug Store & Retail Pharmacies, Hospital Pharmacies, & Online Pharmacies. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

Free Valuable Insights: The Global Pigmentation Disorder Treatment Market is Predict to reach $1.2 Billion by 2030, at a CAGR of 4.8%

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Bausch Health Companies Inc, Glenmark Pharmaceuticals Limited, Obagi Cosmeceuticals LLC, AbbVie, Inc., Dermavant Sciences, Inc. (Roivant Sciences Ltd.), Incyte Corporation, Dr. Reddy’s Laboratories Ltd., Galderma S.A., Viatris, Inc. (Mylan N.V.), and Pfizer, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Type

• Vitiligo
• Melasma
• Others

By Treatment

• Corticosteroids
• Calcineurin Inhibitor
• Others

By Distribution Channel

• Drug Store & Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

• Bausch Health Companies Inc
• Glenmark Pharmaceuticals Limited
• Obagi Cosmeceuticals LLC
• AbbVie, Inc.
• Dermavant Sciences, Inc. (Roivant Sciences Ltd.)
• Incyte Corporation
• Dr.Reddy’s Laboratories Ltd.
• Galderma S.A.
• Viatris, Inc. (Mylan N.V.)
• Pfizer, Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Pigmentation Disorder Treatment Market, by Type
1.4.2 Asia Pacific Pigmentation Disorder Treatment Market, by Treatment
1.4.3 Asia Pacific Pigmentation Disorder Treatment Market, by Distribution Channel
1.4.4 Asia Pacific Pigmentation Disorder Treatment Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter Five Forces Analysis

Chapter 4. Asia Pacific Pigmentation Disorder Treatment Market, By Type
4.1 Asia Pacific Vitiligo Market, By Country
4.2 Asia Pacific Melasma Market, By Country
4.3 Asia Pacific Others Market, By Country

Chapter 5. Asia Pacific Pigmentation Disorder Treatment Market, By Treatment
5.1 Asia Pacific Corticosteroids Market, By Country
5.2 Asia Pacific Calcineurin Inhibitor Market, By Country
5.3 Asia Pacific Others Market, By Country

Chapter 6. Asia Pacific Pigmentation Disorder Treatment Market, By Distribution Channel
6.1 Asia Pacific Drug Store & Retail Pharmacies Market, By Country
6.2 Asia Pacific Hospital Pharmacies Market, By Country
6.3 Asia Pacific Online Pharmacies Market, By Country

Chapter 7. Asia Pacific Pigmentation Disorder Treatment Market, By Country
7.1 China Pigmentation Disorder Treatment Market
7.1.1 China Pigmentation Disorder Treatment Market, By Type
7.1.2 China Pigmentation Disorder Treatment Market, By Treatment
7.1.3 China Pigmentation Disorder Treatment Market, By Distribution Channel
7.2 Japan Pigmentation Disorder Treatment Market
7.2.1 Japan Pigmentation Disorder Treatment Market, By Type
7.2.2 Japan Pigmentation Disorder Treatment Market, By Treatment
7.2.3 Japan Pigmentation Disorder Treatment Market, By Distribution Channel
7.3 India Pigmentation Disorder Treatment Market
7.3.1 India Pigmentation Disorder Treatment Market, By Type
7.3.2 India Pigmentation Disorder Treatment Market, By Treatment
7.3.3 India Pigmentation Disorder Treatment Market, By Distribution Channel
7.4 South Korea Pigmentation Disorder Treatment Market
7.4.1 South Korea Pigmentation Disorder Treatment Market, By Type
7.4.2 South Korea Pigmentation Disorder Treatment Market, By Treatment
7.4.3 South Korea Pigmentation Disorder Treatment Market, By Distribution Channel
7.5 Singapore Pigmentation Disorder Treatment Market
7.5.1 Singapore Pigmentation Disorder Treatment Market, By Type
7.5.2 Singapore Pigmentation Disorder Treatment Market, By Treatment
7.5.3 Singapore Pigmentation Disorder Treatment Market, By Distribution Channel
7.6 Malaysia Pigmentation Disorder Treatment Market
7.6.1 Malaysia Pigmentation Disorder Treatment Market, By Type
7.6.2 Malaysia Pigmentation Disorder Treatment Market, By Treatment
7.6.3 Malaysia Pigmentation Disorder Treatment Market, By Distribution Channel
7.7 Rest of Asia Pacific Pigmentation Disorder Treatment Market
7.7.1 Rest of Asia Pacific Pigmentation Disorder Treatment Market, By Type
7.7.2 Rest of Asia Pacific Pigmentation Disorder Treatment Market, By Treatment
7.7.3 Rest of Asia Pacific Pigmentation Disorder Treatment Market, By Distribution Channel

Chapter 8. Company Profiles
8.1 Bausch Health Companies Inc
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 SWOT Analysis
8.2 Glenmark Pharmaceuticals Limited
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 SWOT Analysis
8.3 Obagi Cosmeceuticals LLC
8.3.1 Company Overview
8.3.2 SWOT Analysis
8.4 AbbVie, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.5 Dermavant Sciences, Inc. (Roivant Sciences Ltd.)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Research & Development Expenses
8.5.4 SWOT Analysis
8.6 Incyte Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Research & Development Expenses
8.6.3.1 Acquisition and Mergers:
8.6.3.2 Trials and Approvals:
8.6.4 SWOT Analysis
8.7 Dr. Reddy’s Laboratories Ltd.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Galderma S.A.
8.8.1 Company Overview
8.9 Viatris, Inc. (Mylan N.V.)
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental Analysis
8.9.4 Research & Development Expense
8.9.5 SWOT Analysis
8.10. Pfizer, Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional & Segmental Analysis
8.10.4 Research & Development Expense
8.10.5 SWOT Analysis

TABLE 1 Asia Pacific Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
TABLE 2 Asia Pacific Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
TABLE 3 Asia Pacific Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
TABLE 4 Asia Pacific Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
TABLE 5 Asia Pacific Vitiligo Market, By Country, 2019 - 2022, USD Million
TABLE 6 Asia Pacific Vitiligo Market, By Country, 2023 - 2030, USD Million
TABLE 7 Asia Pacific Melasma Market, By Country, 2019 - 2022, USD Million
TABLE 8 Asia Pacific Melasma Market, By Country, 2023 - 2030, USD Million
TABLE 9 Asia Pacific Others Market, By Country, 2019 - 2022, USD Million
TABLE 10 Asia Pacific Others Market, By Country, 2023 - 2030, USD Million
TABLE 11 Asia Pacific Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
TABLE 12 Asia Pacific Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
TABLE 13 Asia Pacific Corticosteroids Market, By Country, 2019 - 2022, USD Million
TABLE 14 Asia Pacific Corticosteroids Market, By Country, 2023 - 2030, USD Million
TABLE 15 Asia Pacific Calcineurin Inhibitor Market, By Country, 2019 - 2022, USD Million
TABLE 16 Asia Pacific Calcineurin Inhibitor Market, By Country, 2023 - 2030, USD Million
TABLE 17 Asia Pacific Others Market, By Country, 2019 - 2022, USD Million
TABLE 18 Asia Pacific Others Market, By Country, 2023 - 2030, USD Million
TABLE 19 Asia Pacific Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
TABLE 20 Asia Pacific Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
TABLE 21 Asia Pacific Drug Store & Retail Pharmacies Market, By Country, 2019 - 2022, USD Million
TABLE 22 Asia Pacific Drug Store & Retail Pharmacies Market, By Country, 2023 - 2030, USD Million
TABLE 23 Asia Pacific Hospital Pharmacies Market, By Country, 2019 - 2022, USD Million
TABLE 24 Asia Pacific Hospital Pharmacies Market, By Country, 2023 - 2030, USD Million
TABLE 25 Asia Pacific Online Pharmacies Market, By Country, 2019 - 2022, USD Million
TABLE 26 Asia Pacific Online Pharmacies Market, By Country, 2023 - 2030, USD Million
TABLE 27 Asia Pacific Pigmentation Disorder Treatment Market, By Country, 2019 - 2022, USD Million
TABLE 28 Asia Pacific Pigmentation Disorder Treatment Market, By Country, 2023 - 2030, USD Million
TABLE 29 China Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
TABLE 30 China Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
TABLE 31 China Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
TABLE 32 China Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
TABLE 33 China Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
TABLE 34 China Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
TABLE 35 China Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
TABLE 36 China Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
TABLE 37 Japan Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
TABLE 38 Japan Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
TABLE 39 Japan Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
TABLE 40 Japan Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
TABLE 41 Japan Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
TABLE 42 Japan Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
TABLE 43 Japan Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
TABLE 44 Japan Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
TABLE 45 India Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
TABLE 46 India Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
TABLE 47 India Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
TABLE 48 India Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
TABLE 49 India Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
TABLE 50 India Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
TABLE 51 India Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
TABLE 52 India Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
TABLE 53 South Korea Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
TABLE 54 South Korea Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
TABLE 55 South Korea Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
TABLE 56 South Korea Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
TABLE 57 South Korea Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
TABLE 58 South Korea Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
TABLE 59 South Korea Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
TABLE 60 South Korea Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
TABLE 61 Singapore Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
TABLE 62 Singapore Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
TABLE 63 Singapore Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
TABLE 64 Singapore Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
TABLE 65 Singapore Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
TABLE 66 Singapore Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
TABLE 67 Singapore Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
TABLE 68 Singapore Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
TABLE 69 Malaysia Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
TABLE 70 Malaysia Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
TABLE 71 Malaysia Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
TABLE 72 Malaysia Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
TABLE 73 Malaysia Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
TABLE 74 Malaysia Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
TABLE 75 Malaysia Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
TABLE 76 Malaysia Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
TABLE 77 Rest of Asia Pacific Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
TABLE 78 Rest of Asia Pacific Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
TABLE 79 Rest of Asia Pacific Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
TABLE 80 Rest of Asia Pacific Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
TABLE 81 Rest of Asia Pacific Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
TABLE 82 Rest of Asia Pacific Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
TABLE 83 Rest of Asia Pacific Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
TABLE 84 Rest of Asia Pacific Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
TABLE 85 Key Information – Bausch Health Companies Inc
TABLE 86 Key Information – Glenmark Pharmaceuticals Limited
TABLE 87 Key Information – Obagi Cosmeceuticals LLC
TABLE 88 Key Information – AbbVie, Inc.
TABLE 89 Key Information – Dermavant Sciences, Inc.
TABLE 90 Key Information – Incyte Corporation
TABLE 91 Key Information – Dr. Reddy’s Laboratories Ltd.
TABLE 92 Key Information – Galderma S.A.
TABLE 93 Key Information – Viatris, Inc.
TABLE 94 Key Information – Pfizer, Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 Asia Pacific Pigmentation Disorder Treatment Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting the Pigmentation Disorder Treatment Market
FIG 4 Porter’s Five Forces Analysis – Pigmentation Disorder Treatment Market
FIG 5 Asia Pacific Pigmentation Disorder Treatment Market share, By Type, 2022
FIG 6 Asia Pacific Pigmentation Disorder Treatment Market share, By Type, 2030
FIG 7 Asia Pacific Pigmentation Disorder Treatment Market, By Type, 2019 - 2030, USD Million
FIG 8 Asia Pacific Pigmentation Disorder Treatment Market share, By Treatment, 2022
FIG 9 Asia Pacific Pigmentation Disorder Treatment Market share, By Treatment, 2030
FIG 10 Asia Pacific Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2030, USD Million
FIG 11 Asia Pacific Pigmentation Disorder Treatment Market share, By Distribution Channel, 2022
FIG 12 Asia Pacific Pigmentation Disorder Treatment Market share, By Distribution Channel, 2030
FIG 13 Asia Pacific Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2030, USD Million
FIG 14 Asia Pacific Pigmentation Disorder Treatment Market share, By Country, 2022
FIG 15 Asia Pacific Pigmentation Disorder Treatment Market share, By Country, 2030
FIG 16 Asia Pacific Pigmentation Disorder Treatment Market, By Country, 2019 - 2030, USD Million
FIG 17 SWOT Analysis: Bausch Health Companies Inc
FIG 18 SWOT Analysis: Glenmark Pharmaceuticals Limited
FIG 19 SWOT Analysis: Obagi Cosmeceuticals LLC
FIG 20 SWOT Analysis: Dermavant Sciences, Inc.
FIG 21 SWOT Analysis: Incyte Corporation
FIG 22 SWOT Analysis: Dr. Reddy’s Laboratories Ltd.
FIG 23 SWOT Analysis: Viatris, Inc.
FIG 24 SWOT Analysis: Pfizer, Inc.